<DOC>
	<DOC>NCT02415894</DOC>
	<brief_summary>The goal of this study is to examine the effectiveness and feasibility of a mifepristone-misoprostol medical abortion regimen in terminating pregnancies 13-22 weeks in Ukraine.</brief_summary>
	<brief_title>Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Ukraine</brief_title>
	<detailed_description />
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Having an ongoing pregnancy of 1322 weeks gestation Be willing to undergo surgical completion if necessary Have no contraindications to study procedures, according to provider Be willing and able to consent to participate in the study Be willing to follow study procedures Known allergy to mifepristone or misoprostol/prostaglandin Any contraindications to vaginal delivery, including placenta previa Unable to provide consent</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>